PRODUCT NAME:

Chlamydia Pneumoniae/Mycoplasma Pneumoniae IgM Antibody Determination Kit (Fluorescence Immunochromatographic Assay) Abbreviation: CP/MP-IgM Ab 

INTENDED USE:

Chlamydia Pneumoniae/Mycoplasma Pneumoniae IgM Antibody Determination Kit is an in vitro diagnostic test for qualitative detection of CP/MP-IgM antibody in human serum, plasma and whole blood specimens. Chlamydia pneumoniae (CP) is a new species named in 1989, it has only one serotype and the representative strain is TWAR. It is an important respiratory pathogen. It is transmitted by droplets and mainly causes atypical pneumonia in human. It can also cause bronchitis, pharyngitis, sinusitis, otitis media, iritis, hepatitis, myocarditis, endocarditis, and meningitis, erythema nodosum and other diseases. It is also one of the important pathogenic bacteria of AIDS, leukemia and other secondary infections. In addition, epidemiological and etiological studies believe that Chlamydia pneumoniae infection is related to cardiovascular disease, which has attracted great attention from scholars from all over the world. Early chlamydia infection is characterized by the appearance of IgM antibodies within 2 to 4 weeks, followed by IgA and IgG responses within 6 to 8 weeks. After acute infection with Chlamydia pneumoniae, IgM antibodies will disappear within 2 to 6 months, IgG antibody titers will gradually decrease, and IgA antibodies tend to disappear rapidly. By the time a patient presents with symptoms, IgM levels are already high. Therefore, the detection of Chlamydia pneumoniae IgM antibody can be used as an important diagnostic indicator for the acute phase infection of Chlamydia pneumoniae. Mycoplasma pneumoniae (MP) belongs to the genus Mycoplasma of the family Mycoplasma, Mollicutes, and is a prokaryotic microorganism without cell walls that can grow and reproduce on an inanimate medium and is the smallest and difficult to stain between viruses and bacteria. After Mycoplasma pneumoniae invades the body as a pathogen, the immune system reacts to produce specific IgM antibodies. Generally, IgM antibodies appear in 1 week after infection, reach the peak in 3-4 weeks, and then gradually decrease. As the incubation period of MP infection is 2-3 weeks, IgM has reached a very high level when patients go to the hospital with symptoms. Therefore, the detection of MP IgM can be used as the main diagnostic index of MP acute infection.